Effect of Upadacitinib on Disease Activity, Pain, Fatigue, Function, Health-Related Quality of Life and Work Productivity for Biologic Refractory Ankylosing Spondylitis

Abstract Introduction Patients with ankylosing spondylitis (AS) have significant unmet treatment needs, despite advancements in biologic therapies. This study evaluated the impact of upadacitinib on clinically meaningful improvement in patient-reported outcomes (PROs) assessing disease activity, pai...

Full description

Bibliographic Details

Published in:	Rheumatology and Therapy
Main Authors:	Victoria Navarro-Compán, Xenofon Baraliakos, Marina Magrey, Andrew Östör, Christopher D. Saffore, Manish Mittal, In-Ho Song, Fabiana Ganz, Jayne Stigler, Atul Deodhar
Format:	Article
Language:	English
Published:	Adis, Springer Healthcare 2023-02-01
Subjects:	Ankylosing spondylitis Axial spondyloarthritis Patient-reported outcomes Health-related quality of life Upadacitinib
Online Access:	https://doi.org/10.1007/s40744-023-00536-2